Latest Breaking News On - Prnewswire eiger biopharmaceuticals inc - Page 8 : comparemela.com

Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19 on Thursday, March 17, 2022

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies.

Sylvia wheelerAljanae reynoldsPrnewswire eiger biopharmaceuticals incEiger biopharmaceuticals incLive conference callHepatitis delta virusPeginterferon lambdaWheelhouse life science advisorsWheelhouse life scienceEiger biopharmaceuticals

Eiger BioPharmaceuticals to Ho - GuruFocus com

GuruFocus Article or News written by PRNewswire and the topic is about:

Ohad etzionOspedale maggiore policlinicoPietro lamperticoNorah terraultHepatology divisionDepartment of gastroenterologyFaculty of health sciencesPrnewswire eiger biopharmaceuticals incSoroka university medical centerBen gurion university of the negevEiger biopharmaceuticals incA migliavacca centerUniversity of milanKey opinion leaderHepatitis delta virusPeginterferon lambda

Eiger BioPharmaceuticals to Host and Webcast Virtual Key Opinion Leader Event on Hepatitis Delta Virus Monday, November 15

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Ohad etzionOspedale maggiore policlinicoPietro lamperticoNorah terraultHepatology divisionDepartment of gastroenterologyFaculty of health sciencesPrnewswire eiger biopharmaceuticals incSoroka university medical centerBen gurion university of the negevEiger biopharmaceuticals incA migliavacca centerUniversity of milanKey opinion leaderHepatitis delta virusPeginterferon lambda

Eiger BioPharmaceuticals to Participate in Upcoming September 2021 Investor Conferences

Eiger BioPharmaceuticals to Participate in Upcoming September 2021 Investor Conferences
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

David coryPrnewswire eiger biopharmaceuticals incDrug development strategies for rare diseaseEuropean medicines agencyEiger biopharmaceuticals incAnnual biopharma virtualDrug development strategiesEiger biopharmaceuticalsHepatitis delta virusPeginterferon lambdaHutchinson gilford progeria syndromeMarketing authorization applicationChief financial